• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Investigation of the relationship between breast cancer and clinical symptoms of polycystic ovarian syndrome: a case-control study.探讨乳腺癌与多囊卵巢综合征临床症状之间的关系:一项病例对照研究。
BMC Womens Health. 2024 Nov 2;24(1):586. doi: 10.1186/s12905-024-03421-4.
2
Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study.一项基于人群的病例对照研究中的多囊卵巢综合征(PCOS)、相关症状/后遗症及乳腺癌风险
Cancer Causes Control. 2016 Mar;27(3):403-14. doi: 10.1007/s10552-016-0716-7. Epub 2016 Jan 21.
3
A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.多囊卵巢综合征女性中一种与内脏脂肪指数相关的饮食模式及心脏代谢特征
Clin Nutr. 2016 Oct;35(5):1181-7. doi: 10.1016/j.clnu.2015.10.007. Epub 2015 Nov 25.
4
A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.一项基于全国人口的多囊卵巢综合征女性患子宫癌、卵巢癌和乳腺癌风险的回顾性队列研究。
Oncologist. 2015 Jan;20(1):45-9. doi: 10.1634/theoncologist.2014-0311. Epub 2014 Nov 19.
5
A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.一项基于鹿特丹标准的多囊卵巢综合征四种表型中胰岛素抵抗和代谢综合征的病例对照观察性研究。
Reprod Health. 2015 Jan 16;12:7. doi: 10.1186/1742-4755-12-7.
6
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.根据鹿特丹标准与包括抗苗勒管激素在内的修订标准,正常人群中多囊卵巢综合征的患病率。
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
7
Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.新推荐的多囊卵巢综合征成年女性窦卵泡计数截断值对多囊卵巢的影响。
Hum Reprod. 2020 Mar 27;35(3):652-659. doi: 10.1093/humrep/deaa012.
8
Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.青少年月经不调和高雄激素血症与多囊卵巢综合征及日后不孕有关:1986年芬兰北部出生队列研究
Hum Reprod. 2014 Oct 10;29(10):2339-51. doi: 10.1093/humrep/deu200. Epub 2014 Aug 1.
9
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.多囊卵巢综合征女性的卵巢手术以缓解症状
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2.
10
Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.中国多囊卵巢综合征女性的临床特征、代谢特征和表型:一项大规模病例对照研究。
Arch Gynecol Obstet. 2013 Mar;287(3):525-31. doi: 10.1007/s00404-012-2568-z. Epub 2012 Oct 30.

本文引用的文献

1
Polycystic ovary syndrome and risk of breast cancer in premenopausal and postmenopausal women: a nationwide population-based cohort study.多囊卵巢综合征与绝经前和绝经后妇女乳腺癌风险:一项全国基于人群的队列研究。
Breast Cancer Res Treat. 2024 Dec;208(3):535-542. doi: 10.1007/s10549-024-07467-8. Epub 2024 Aug 21.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis.多囊卵巢综合征通过中介因子与不同乳腺癌亚型的因果关系途径:多变量孟德尔随机分析。
J Ovarian Res. 2023 Nov 13;16(1):215. doi: 10.1186/s13048-023-01306-y.
4
Estrogens and the risk of breast cancer: A narrative review of literature.雌激素与乳腺癌风险:文献综述
Heliyon. 2023 Sep 17;9(9):e20224. doi: 10.1016/j.heliyon.2023.e20224. eCollection 2023 Sep.
5
Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association.多囊卵巢综合征女性患妇科癌症的风险及关联的病理生理学
Cureus. 2023 Apr 7;15(4):e37266. doi: 10.7759/cureus.37266. eCollection 2023 Apr.
6
A prospective cohort study of infertility and cancer incidence.前瞻性队列研究不孕与癌症发病情况。
Fertil Steril. 2023 Jul;120(1):134-142. doi: 10.1016/j.fertnstert.2023.02.028. Epub 2023 Feb 25.
7
Obesity and endocrine-related cancer: The important role of IGF-1.肥胖与内分泌相关癌症:IGF-1 的重要作用。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1093257. doi: 10.3389/fendo.2023.1093257. eCollection 2023.
8
Global trends in polycystic ovary syndrome research: A 10-year bibliometric analysis.多囊卵巢综合征研究的全球趋势:一项 10 年文献计量分析。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1027945. doi: 10.3389/fendo.2022.1027945. eCollection 2022.
9
Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis.多囊卵巢综合征女性患子宫内膜癌、卵巢癌和乳腺癌的风险:一项系统评价和荟萃分析。
Int J Reprod Biomed. 2022 Dec 10;20(11):893-914. doi: 10.18502/ijrm.v20i11.12357. eCollection 2022 Nov.
10
Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations.多囊卵巢综合征:聚焦种族和地理差异影响的最新综述
Life (Basel). 2022 Nov 25;12(12):1974. doi: 10.3390/life12121974.

探讨乳腺癌与多囊卵巢综合征临床症状之间的关系:一项病例对照研究。

Investigation of the relationship between breast cancer and clinical symptoms of polycystic ovarian syndrome: a case-control study.

机构信息

Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.

Nursing and Midwifery Care Research Center (NMCRC) and Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Womens Health. 2024 Nov 2;24(1):586. doi: 10.1186/s12905-024-03421-4.

DOI:10.1186/s12905-024-03421-4
PMID:39488687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531183/
Abstract

BACKGROUND

Breast cancer is the most commonly diagnosed cancer among women worldwide, and it is associated with significant number of metabolic and reproductive risk factors. Despite the overlap between hormonal and metabolic factors involved in the development of PCOS and many known risk factors for breast cancer, the relationship between PCOS and breast cancer, the most common type of cancer among women, remains unknown. This study was conducted with the aim of determining the relationship between breast cancer and clinical symptoms of PCOS.

METHODS

This case-control study was conducted on 285 women with breast cancer and 285 healthy women referred to three centers in Tehran in 2023. Both the case and control groups were matched in terms of age and body mass index. The data collection tool in this study was a researcher-made data registration form, that was completed in person by qualified individuals. A history of PCOS was identified according to the Rotterdam criteria. Women aged 15-49 years who were able to read and write were included in the study. The case group had a history of breast cancer, while the control group did not. Participants who did not consent to having their data use in the analysis were excluded. Data was analyzed using an independent t-test, a chi-square test and a logistic regression model.

RESULTS

The mean age of the participants in the case group was 43.05 ± 4.92 years and that of the control group was 42.78 ± 5.06 years. The two groups showed a statistically significant difference in terms of PCOS history (p < 0.001). After adjusting for confounding variables, the logistic regression model showed that women with PCOS had a significantly higher chance of developing breast cancer (0R: 3.677, 95%CI: 1.529-8.840, P = 0.004). Among PCOS symptoms, women with a history of hirsutism had a higher chance of developing breast cancer (OR: 2.188, 95% CI: 1.014-4.720, P = 0.046).

CONCLUSION

The findings of the present study suggest that PCOS is a risk factor for breast cancer. Well-designed further studies are highly recommended to determine the role of PCOS in predicting breast cancer.

摘要

背景

乳腺癌是全球女性最常见的癌症,与大量代谢和生殖风险因素有关。尽管多囊卵巢综合征(PCOS)涉及的激素和代谢因素与许多已知的乳腺癌风险因素重叠,但 PCOS 与乳腺癌之间的关系,即女性最常见的癌症类型,仍然未知。本研究旨在确定乳腺癌与 PCOS 临床症状之间的关系。

方法

本病例对照研究于 2023 年在德黑兰的三个中心对 285 名乳腺癌女性和 285 名健康女性进行,病例组和对照组在年龄和体重指数方面相匹配。本研究的数据收集工具是由研究人员制作的个人资料登记表,由合格人员亲自填写。根据鹿特丹标准确定 PCOS 病史。纳入研究的对象为年龄在 15-49 岁、能读写的女性。病例组有乳腺癌病史,对照组没有。不同意将其数据用于分析的参与者被排除在外。使用独立 t 检验、卡方检验和逻辑回归模型对数据进行分析。

结果

病例组参与者的平均年龄为 43.05±4.92 岁,对照组为 42.78±5.06 岁。两组在 PCOS 病史方面存在统计学显著差异(p<0.001)。调整混杂变量后,逻辑回归模型显示 PCOS 女性患乳腺癌的风险显著增加(OR:3.677,95%CI:1.529-8.840,P=0.004)。在 PCOS 症状中,有高雄激素血症史的女性患乳腺癌的风险更高(OR:2.188,95%CI:1.014-4.720,P=0.046)。

结论

本研究结果表明,PCOS 是乳腺癌的一个危险因素。强烈建议进行设计良好的进一步研究,以确定 PCOS 在预测乳腺癌中的作用。